window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

cancer treatment

  • Clinical & Regulatory,Therapeutic Areas

    Baptist Health and START expand access to early-phase cancer trials in South Florida

    Patients across South Florida are set to gain greater access [...]

    June 6, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    UK nuclear materials to power new precision cancer therapies

    The UK is launching a major programme to convert used [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    VIVES Partners joins Nuclidium AG’s €84M Series B Financing to advance copper-based radiopharmaceuticals

    VIVES Partners, managing company of VIVES Funds, has joined a [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Orano Med invests $5M to expand US radiopharma capabilities

    Orano Med has expanded its US research and development center [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation

    Generic Paclitaxel launch expands US access to chemotherapy for metastatic cancer

    Meitheal introduces albumin-bound injectable version under license from Hong Kong [...]

    May 5, 2026
  • Advanced Therapies,Opinion & Events

    CAR T Vision coalition sets goal to double access to therapy by 2030

    A new international alliance, CAR T Vision, launched today with [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events

    New partnership aims to tackle European shortages of key oncology drugs

    Bionical Emas has signed an exclusive global clinical trial supply [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Pierre Fabre moves closer to first-line approval for BRAFTOVI in BRAF-mutant metastatic colorectal cancer
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Skyhawk reports encouraging 12-month Huntington’s disease data for SKY-0515
    Categories: Advanced Therapies, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • NICE backs serplulimab for extensive-stage small cell lung cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top